Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model

Effective treatments for chronic limb-threatening ischemia are lacking. (Pre)clinical studies on administration of bone marrow (BM) mononuclear cells (MNCs) and BM-derived mesenchymal stromal cells (MSCs) have shown variable results and no studies have directly compared administration of human BM MN...

Descripción completa

Detalles Bibliográficos
Autores principales: van Rhijn-Brouwer, Femke Christina Ching-Chuan, Gremmels, Hendrik, Den Ouden, Krista, Teraa, Martin, Fledderus, Joost Ougust, Verhaar, Marianne Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057881/
https://www.ncbi.nlm.nih.gov/pubmed/35152731
http://dx.doi.org/10.1089/scd.2021.0261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057881/
https://www.ncbi.nlm.nih.gov/pubmed/35152731
http://dx.doi.org/10.1089/scd.2021.0261

Ejemplares similares